Status:
COMPLETED
Comparative Single-dose Bioavailability Clinical Study of Different Coenzyme Q10 Products
Lead Sponsor:
University of Primorska
Collaborating Sponsors:
Biovis d.o.o.
Conditions:
Coenzyme Q Deficiency
Eligibility:
All Genders
40-55 years
Phase:
NA
Brief Summary
The randomized, open-label, three period crossover single-dose bioavailability study with three coenzyme Q10 products
Detailed Description
The randomized, open-label, three period crossover single-dose bioavailability study with three coenzyme Q10 products will include 25 subjects who will test three different coenzyme Q10 products. Seru...
Eligibility Criteria
Inclusion
- subject informed consent form
- aged between 40 and 55 years old
- body mass for women 65± 5 kg and for men 85± 5 kg
- non-smoking
- healthy, without cardio-vascular diseases, diabetes, neurodegenerative diseases
- absence of any prescribed medication during the study
- willing to avoid a consumption of any food supplements at least 2 weeks before and during the study
- willing to study all study procedures
Exclusion
- cardio-vascular diseases,
- diabetes,
- neurodegenerative diseases,
- gastrointestinal disorders
- hypotension
- pregnancy
- breast-feeding
- intake of any prescribed medication within two week of the beginning of the study
- intake of any food supplements within two week of the beginning of the study
- drug or alcohol abuse
Key Trial Info
Start Date :
March 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2022
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05272228
Start Date
March 9 2022
End Date
July 15 2022
Last Update
July 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Primorska
Izola, Slovenia, 6310